Home › Tricuspid Valve Insufficiency › California › San Francisco
Tricuspid Valve Insufficiency clinical trials in San Francisco, CA
4 studies for Tricuspid Valve Insufficiency are looking for participants at sites in and around San Francisco (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Transcatheter Tricuspid Valve Replacement With the Medtronic Intrepid™ Transcatheter Tricuspid Valve Replacement (TTVR) System in Severe Tricuspid Regurgitation
Recruiting
- Kaiser Permanente San Francisco Medical Center, San Francisco
VDyne TriNova Transcatheter Tricuspid Valve Replacement Study to Evaluate Safety and Clinical Efficacy in Patients With Symptomatic Severe Tricuspid Valve Regurgitation (TRIVITA Pivotal Trial)
Recruiting
- Sutter Health/ California Pacific Medical Center, San Francisco
- Kaiser Permanente San Francisco, San Francisco
Early Feasibility Study (EFS) Laplace Transcatheter Tricuspid Valve Replacement (TTVR) System
Recruiting
- Kaiser Permanente, San Francisco
Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial
Recruiting
- University of California, San Francisco, San Francisco
Tricuspid Valve Insufficiency trials in other cities
- New York City, NY10 studies
- Atlanta, GA8 studies
- Cincinnati, OH7 studies
- The Bronx, NY6 studies
- Nashville, TN5 studies
- Phoenix, AZ5 studies
- Chicago, IL5 studies
- Rochester, MN5 studies
- Portland, OR5 studies
- Los Angeles, CA4 studies
- Thousand Oaks, CA4 studies
- Philadelphia, PA4 studies
Other studies in San Francisco
- Prostate Cancer44 studies
- Breast Cancer40 studies
- Cancer (all types)38 studies
- Non-Small Cell Lung Cancer37 studies
- Heart Failure29 studies
- Metastatic Cancer25 studies
- Lung Cancer23 studies
- Melanoma21 studies
- Ovarian Cancer20 studies
- Cardiovascular Disease20 studies
- Pancreatic Cancer19 studies
- Glioblastoma19 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.